Cost of anemia in the elderly

Journal of the American Geriatrics Society

Volumn 51, Issue 3 SUPPL., 2003, Pages 14-17

  Robinson, Bruce ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA SARASOTA MANATEE   (United States)

^b Department of Geriatrics ^*  (United States)

Author keywords

Aging; Anemia; Healthcare costs

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

AGED; ANEMIA; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; HEALTH CARE COST; HEALTH STATUS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; MENTAL HEALTH; POPULATION RESEARCH; TREATMENT OUTCOME;

EID: 0037344124     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1532-5415.51.3s.5.x     Document Type: Conference Paper

References (23)

1. The 2001 Annual Report of the Board of Trustees of the Federal Old-Age and Survivors Insurance and Disability Insurance Trust Funds. Washington, DC: Office of the Chief Actuary, Social Security Administration, 2001.
2. Besdine RW, Rubenstein LZ, Cassel C. Nursing home residents need physicians' services. Ann Intern Med 1994;120:616-618.
3. Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med 2000;342:1409-1415.
4. Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980;303:130-136.
5. Branch LG, Guralnik JM, Foley DJ et al. Active life expectancy for 10,000 Caucasian men and women in three communites. J Getontol 1991;46: M145-M150.
6. Herndon JG, Helmick CG, Sattin RW et al. Chronic medical conditions and risk of fall injury events at home in older adults. J Am Geriatr Soc 1997;45: 739-743.
7. Beard MC, Kokmen E, O'Brain P et al. Risk of Alzheimer's disease among elderly patients with anemia: Population based investigations in Olmstead County. Olmstead County, Minnesota. Ann Epidermiol 1997;7:219-224.
8. Katz IR, Beaston-Wimmer P, Parmelee P et al. Failure to thrive in the elderly. Exploration of the concept and delineation of psychiatric components. J Geriatr Psychiatry Neurol 1993;6:161-169.
9. Anand IS, Chandrashekhar Y, Fertari R et al. Pathogenesis of oedema in chronic severe anaemia: Studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993;70:357-362.
10. Kamenetz Y, Beloosesky Y, Zeltzet C et al. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly. Aging Clin Exp Res 1998;10:32-38.
11. Hauer K, Rost B, Rutschle K et al. Exercise training for rehabilitation and secondary prevention of falls in geriatric patients with a history of injurious falls. J Am Geriatr Soc 2001;49:10-20.
12. Rizzo JA, Friedkin R, Williams CS et al. Health care utilization and costs in a medicare population by fall status. Med Care 1998;36:1174-1188.
13. Fuller GF. Falls in the elderly. Am Fam Physician 2000;61:2159-2168.
14. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 1998;88:1337-1342.
15. Greenberg PE, Stiglin LE, Finkelstein SN et al. The economic burden of depression in 1990. J Clin Psychiatry 1993;54:405-418.
16. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000;35:1737-1744.
17. Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT antagonists. Eur J Heart Fail 2000;2:393-398.
18. Biasucci LM, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-877.
19. Fonatow GC, Stevenson LW, Walden JA et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 1997;30: 725-732.
20. Eschbach J, Egrie J, Downing M et al. Correction of anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 1987; 316:73-78.
21. Levin N. Maximizing patient benefits with epoetin alfa therapy: National cooperative tHu erythropoietin study in patients with chronic renal failure - an interim report. Am J Kidney Dis 1993;22:3-12.
22. Marsh J, Brown W, Wolcott D et al. rHuEPO treatment improves brain and cognitive function in anemic dialysis patients. Kidney Int 1991;39: 155-163.
23. Revicki D, Brown R, Feeny D et al. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis 1995;25:548-554.